The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2D
Status:
Completed
Trial end date:
2017-12-10
Target enrollment:
Participant gender:
Summary
Delineation of the role of glucagon-like peptide-1 receptor signalling in the
glucose-lowering effect of metformin during meal ingestion in patients with type 2 diabetes.